Additional file 1: Table S1. Differentially expressed miRNAs in 1. Complicated vs uncomplicated P. vivax 2. Complicated P. vivax vs Healthy 3. Complicated P. vivax vs P. falciparum with p-value < 0.05
Additional file 1. Primer sequences used to amplify hrp2 and P. falciparum, P. vivax, P. malariae an...
Additional file 1: Table S1. Origin of pv32 gene sequences from worldwide isolates
Additional file 9. Information about proteins with divergent levels between mild and severe malaria ...
Additional file 3: Figure S2. Venn diagram analysis showing criteria used for the selection of commo...
Additional file 2: Figure S1. Summarized layout for the detailed analysis of PPI networks
Abstract Background In the recent years Plasmodium vivax has been reported to cause severe infection...
Additional file 3: Table S3. Target gene candidates for known and novel miRNAs in An. sinensis
Additional file 4: Differentially expressed genes between SPN and non-neoplastic samples. Table S4 p...
The prediction list of most latent miRNA biomarkers for various investigated diseases has been publi...
Additional file 3: Table S2. List of Pv32 haplotypes identified from 11 countries
Additional file 1: Table S1. PCR protocol and cycling conditions used for malaria diagnosis of P. fa...
Additional file 4: Table S3. Differential expression analysis of circulating serum miRNAs in low-ris...
Additional file 2: Table S2. miRNA mimic sequences for control, miR-17, miR-20a, miR-20b and miR-106...
Additional file 2: Table S1. Haplotype frequencies among 41 P. vivax malaria patients and their asso...
Additional file 1. Genotypes based on the co-prevalence of the drug resistance vivax makers
Additional file 1. Primer sequences used to amplify hrp2 and P. falciparum, P. vivax, P. malariae an...
Additional file 1: Table S1. Origin of pv32 gene sequences from worldwide isolates
Additional file 9. Information about proteins with divergent levels between mild and severe malaria ...
Additional file 3: Figure S2. Venn diagram analysis showing criteria used for the selection of commo...
Additional file 2: Figure S1. Summarized layout for the detailed analysis of PPI networks
Abstract Background In the recent years Plasmodium vivax has been reported to cause severe infection...
Additional file 3: Table S3. Target gene candidates for known and novel miRNAs in An. sinensis
Additional file 4: Differentially expressed genes between SPN and non-neoplastic samples. Table S4 p...
The prediction list of most latent miRNA biomarkers for various investigated diseases has been publi...
Additional file 3: Table S2. List of Pv32 haplotypes identified from 11 countries
Additional file 1: Table S1. PCR protocol and cycling conditions used for malaria diagnosis of P. fa...
Additional file 4: Table S3. Differential expression analysis of circulating serum miRNAs in low-ris...
Additional file 2: Table S2. miRNA mimic sequences for control, miR-17, miR-20a, miR-20b and miR-106...
Additional file 2: Table S1. Haplotype frequencies among 41 P. vivax malaria patients and their asso...
Additional file 1. Genotypes based on the co-prevalence of the drug resistance vivax makers
Additional file 1. Primer sequences used to amplify hrp2 and P. falciparum, P. vivax, P. malariae an...
Additional file 1: Table S1. Origin of pv32 gene sequences from worldwide isolates
Additional file 9. Information about proteins with divergent levels between mild and severe malaria ...